RESEARCH - RA patients don't use routine low-dose aspirin, despite high CV risk

[Guest guest]

RA patients don't use routine low-dose aspirin, despite high CV risk

Rheumawire

December 1, 2005

Janis

San Diego, CA - Rheumatoid arthritis (RA) patients are less likely to take

daily preventive doses of aspirin to reduce cardiovascular (CV) risks,

despite the increased risk of heart attack associated with RA, according to

survey data presented at the 2005 ACR/ARHP Annual Scientific Meeting [1].

" Rheumatologists might be assuming that aspirin prescriptions will be dealt

with by the primary-care physician who will initiate the prophylactic

regimen. We need better communication between rheumatologists and

primary-care physicians so that cardiovascular protection for RA patients

does not fall through the cracks, " said lead author Dr Colglazier (now

in private practice in Crestview Hills, KY).

RA patients one third less likely to use aspirin

The US Preventive Services Task Force recommends routine low-dose aspirin

(81 mg-325 mg/day) for adults who are at increased risk of having a heart

attack over the next 10 years. RA is associated with such a CV risk.

Colglazier et al surveyed 14 114 RA patients semiannually for three years as

part of an arthritis-outcomes study. Results in those patients were compared

with outcomes in 4009 patients with noninflammatory rheumatic disorders.

Colglazier found that, adjusted for age and sex, RA patients had an expected

greater risk of myocardial infarction (MI) compared with noninflammatory

disorders (odds ratio [OR] 1.7.)

This probably reflects in part the fact that RA patients were much less

likely to take low-dose aspirin (OR 0.67), and this did not change when

history of MI was added as a covariate.

The age- and sex-adjusted rates of low-dose aspirin use were 18.4% for RA

patients and 25.1% for patients with noninflammatory rheumatic diseases.

Among RA patients, men were more likely to use low-dose aspirin (OR 1.6).

COX-2-inhibitor use was associated with greater use of low-dose aspirin (OR

1.06), as was white ethnicity (OR 1.20). Patients who used nonspecific

NSAIDs were less likely to use low-dose aspirin (OR 0.89), as were patients

with poorer functional status, increased pain, or use of prednisone.

" Although the rate of MI is increased in RA, use of low-dose aspirin by RA

patients is reduced compared with non-RA patients. We were unable to find

any clinical, demographic, or treatment variables that explained this rate

difference. Several possibilities are suggested. Physicians may feel that

the complicated RA treatments weigh against additional therapies. In

addition, package inserts and pharmacists recommend against using aspirin

with methotrexate or NSAIDs. Finally, rheumatologists, as subspecialists,

may not address primary-prevention issues. Although further studies are

needed to understand this discrepancy, rheumatologists should be aware that

RA patients, on average, receive less than the recommended care for

prophylaxis and treatment of CV disorders, " Colglazier said.

Source

1. Colglazier L, Wolfe F, Michaud K, et al. Rheumatoid

arthritis (RA) patients are less likely to be treated with prophylactic

aspirin despite an increased risk of myocardial infarction. 2005 ACR/ARHP

Annual Scientific Meeting; Nov. 12-17, 2005; San Diego, CA. Abstract 1904.

Not an MD

I'll tell you where to go!

Mayo Clinic in Rochester

http://www.mayoclinic.org/rochester

s Hopkins Medicine

http://www.hopkinsmedicine.org